UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
More than 100 UC San Diego Health physicians have been named “Top Docs” in the 2022 San Diego Magazine “Physicians of Exceptional Excellence” survey.
UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.
UC San Diego researchers discover that quality and mix of protein in a type of pancreatic cancer is the determinant of whether the prognosis is poor or very poor.
The School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences earned the designation for the innovative use of iPad in the curriculum.
In a recent collaborative effort, physicians with UC San Diego Health and scientists at the Salk Institute reported a form of intermittent fasting, called time-restricted eating, improved the health of study participants who had been diagnosed with metabolic syndrome.
U.S. News & World Report, June 9
Women's Health, June 3
The New York Times, June 2
The San Diego Union-Tribune, May 23
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
